Calico Life Sciences Llc

This study tests an experimental drug called fosigotifator in people with Vanishing White Matter disease, a rare genetic brain disorder. About 50 adults, children, and infants will receive the drug to see if it is safe and how the body processes it. The study lasts about 4 years …

This early-phase study is testing a new drug called ABBV-CLS-484, alone or combined with other cancer treatments, in people with advanced solid tumors that have spread or cannot be removed. The main goals are to find safe and tolerable doses and to see if the drug can shrink tumo…